13F Insight
DOSSIER · 13F-HR · Q2 2026

BAHL & GAYNOR INC

$21.7B in tracked AUM across 341 positions as of Q2 2026.

B&
CIK 0000872259 · last filed Jun 30, 2026
Total AUM
$21.7B
as of Q2 2026
Holdings
341
—
positions
Whale Score
64
64
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

BAHL & GAYNOR INC filed Q1 2026 13F-HR with $19.8B in disclosed U.S. equity holdings The portfolio is led by Unknown exposure, with top positions including AVGO (4.4%), MSFT (3.5%), JNJ (3.4%). Quarter-over-quarter activity shows 6 new entries and 6 exits, with a net reductive posture across 56 changed positions. Notable reduction: LLY (15.4% reduction) (Eli Lilly & Co).

BAHL & GAYNOR INC reports $19.8B in U.S. equity holdings for Q1 2026, anchored by a Unknown-centric allocation. The top five positions by value span AVGO + MSFT + JNJ + LLY + ABBV, collectively representing a meaningful concentration within the disclosed book.

Core Holdings

  • AVGO (Broadcom Inc) — $0.9B (4.4%)
  • MSFT (Microsoft Corp) — $0.7B (3.5%)
  • JNJ (Johnson & Johnson) — $0.7B (3.4%)
  • LLY (Eli Lilly & Co) — $0.6B (3.1%)
  • ABBV (AbbVie Inc) — $0.6B (3.0%)
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
AVGO
Broadcom Inc
$986M2.6M4.5%02
LLY
Eli Lilly & Co
$787M656K3.6%03
MSFT
Microsoft Corp
$676M1.8M3.1%04
TSM
Taiwan Semiconductor Mfg Ltd S
$671M1.4M3.1%05
ABBV
AbbVie Inc
$652M2.6M3.0%06
JPM
JPMorgan Chase & Co
$625M1.9M2.9%07
WMB
Williams Cos Inc
$503M6.8M2.3%08
JNJ
Johnson & Johnson
$501M2.0M2.3%09
PG
Procter & Gamble Co
$476M3.2M2.2%10
UNH
UnitedHealth Group Inc
$475M1.1M2.2%

Filing history

2026Q2Jun 30
$21.7B▲ 9.3%
341 positionsView →2026Q1Mar 31
$19.8B▲ 0.4%
327 positionsView →2025Q4Dec 31
$19.8B▼ 1.9%
327 positionsView →2025Q3Sep 30
$20.1B▲ 1.9%
326 positionsView →2025Q2Jun 30
$19.8B▲ 0.7%
332 positionsLocked2025Q1Mar 31
$19.6B▲ 3.7%
337 positionsLocked2024Q4Dec 31
$18.9B▼ 2.6%
336 positionsLocked2024Q3Sep 30
$19.4B▲ 8.5%
342 positionsLocked2024Q2Jun 30
$17.9B▼ 0.3%
333 positionsLocked2024Q1Mar 31
$18.0B▲ 8.0%
480 positionsLocked2023Q4Dec 31
$16.6B▲ 6.2%
468 positionsLocked2023Q3Sep 30
$15.7B▼ 4.7%
462 positionsLocked
Showing 12 of 100